The Regulatory Role of IL-10 in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
IL-10, an immunosuppressive cytokine, is considered an important anti-inflammatory modulator of glial activation, preventing inflammation-mediated neuronal degeneration under pathological conditions. In this narrative review, we summarize recent insights about the role of IL-10 in the neurodegeneration associated with neuroinflammation, in diseases such as Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic lateral sclerosis, Alzheimer’s Disease, and Parkinson’s Disease, focusing on the contribution of this cytokine not only in terms of protective action, but also as possibly responsible for clinical worsening. The knowledge of this double face of the same coin, regarding the biological role of the IL-10, could aid the development of targeted therapies useful for limiting neurodegenerative processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 2×
“The IL-10Rβ chain is expressed in a ubiquitous and constitutive manner by all cell types [14] and its principal function seems to be the recruitment of a Janus (Jak) kinase/tyrosine kinase (Tyk) for the signaling pathway [16].”
Backgroundde Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · cited 1×
“Alzheimer’s disease (AD), the most common cause of dementia in older adults, is a chronic neurodegenerative disease characterized by progressive loss of brain cells, formation of extracellular amyloidβ (Aβ) plaques and intracellular neurofibrillary tangles [66].”
BackgroundFiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733 · cited 1×
“It was first described after the analysis for secreted factors by immunomodulatory CD4+ T helper 2 (Th2) mouse lymphocytes (named as anti-inflammatory cells) that can regulate CD4+ T helper 1 (Th1) lymphocytes (reported as pro-inflammatory cells) [2,3].”
BackgroundB-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · cited 1×
“Although MS is primarily considered a T cell-mediated disease, successful B cell depletion with anti-CD20 monoclonal antibodies [46] suggests that these cells play an indispensable role in MS pathogenesis.”
BackgroundCarbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153 · cited 2×
“These observations enforce the idea that both HO-1 and CO play critical roles in mediating the anti-inflammatory effect of IL-10 both in vitro and in vivo [24,25].”
BackgroundMicroglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215 · cited 1×
“In this regard, microglia, representing the resident macrophages, are, in the brain, the only CNS cells of hematopoietic origin, others being glial cells, as neurons, derived from neuroectoderm [30].”
BackgroundInterleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173 · cited 1×
“IL-10 acts in innate as well as in adaptive immunity, both in terms of immunosuppressive and immunostimulatory effects, thus, regulating response in many cell types, such as antigen-presenting cells (APCs), including dendritic cells (DCs), Langerhans cells, and macrophages [4].”
BackgroundHomology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Interleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Kortylewski, M., Kujawski, M., Wang, T., Wei, S., Zhang, S., Pilon-Thomas, S., Niu, G., Kay, H., Mulé, J., Kerr, W. G., et al. (2005) · Nature Medicine · doi:10.1038/nm1325 · Cited by 1,031 · cited 6×
“IL-10 has been described to be produced by almost all leukocytes, including all T cell subsets, monocytes, macrophages, neutrophils, eosinophils, mast cells, dendritic cells (DCs), B and natural killer (NK) cells [9].”
BackgroundInfluentialHeme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019 · cited 4×
“These observations enforce the idea that both HO-1 and CO play critical roles in mediating the anti-inflammatory effect of IL-10 both in vitro and in vivo [24,25].”
BackgroundInfluentialRodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C. F., Yin, L., Pennica, D., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81166-6 · Cited by 853 · cited 1×
“In this context, it was reported that macrophages from Jak1−/−mice do not respond to IL-10, indicating the importance of Jak1 as an obligatory step in IL-10 signaling [20].”
BackgroundThe Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Ziebell, J. M., & Morganti-Kossmann, M. C. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.016 · Cited by 667 · cited 1×
“In this regard, neuroinflammation is characterized by the activation of resident glial cells, committed to central nervous system (CNS) immune surveillance, through the release of cytokines, chemokines, and other mediators, which, in turn, are able to recruit peripheral cells, including lymphocytes, monocytes and neut…”
BackgroundMicroglia: Dynamic Mediators of Synapse Development and Plasticity
Wu, Y., Dissing-Olesen, L., MacVicar, B. A., & Stevens, B. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.008 · Cited by 661 · cited 1×
“It has been well accepted that macrophages can modify their metabolic functions from a heal/growth promoting (M2 macrophages) to a killing/inhibitory phenotype (M1 macrophages) [31].”
BackgroundRegulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R., Poe, J. C., Leonard, W. J., & Tedder, T. F. (2012) · Nature · doi:10.1038/nature11501 · Cited by 634 · cited 1×
“Furthermore, the employment of reinfusion of CD40-dependent IL-10-secreting autologous functional B cells was resulted to be an innovative and efficacious in vivo treatment for severe autoimmune diseases resistant to current therapies, including MS [50].”
BackgroundQin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P., & Cheng, Y. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2742 · Cited by 554 · cited 1×
“A recent report showed increased peripheral concentrations of IL-6, IL-1β, TNFα, IL-2 and IL-10 in patients with PD [83].”
BackgroundOligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438
TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity
Lampropoulou, V., Hoehlig, K., Roch, T., Neves, P., Gómez, E. C., Sweenie, C. H., Hao, Y., Freitas, A. A., Steinhoff, U., Anderton, S. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4763 · Cited by 436 · cited 1×
“Consistent to this finding, previous studies reported that CD40 stimulation triggered continuous IL-10 production by human B cells in response to TLR stimulation correlating with B cell-mediated recovery from EAE by IL-10 production [48,49], promising a novel therapeutic approach for MS.”
ResultWilliams, L., Bradley, L., Smith, A., & Foxwell, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.567 · Cited by 393 · cited 1×
“Fin lly, SOC -3 mediates Jak1-inhibition, resulting in feedback inhibition of the Jak1/Tyk2/STAT3 pathway [23].”
BackgroundMapping of the human IL10 gene and further characterization of the 5' flanking sequence
Eskdale, J., Kube, D., Tesch, H., & Gallagher, G. (1997) · Immunogenetics · doi:10.1007/s002510050250 · Cited by 384 · cited 2×
“IL-10, also known as human cytokine synthesis inhibitory factor (CSIF), is a homodimeric polypeptide of 17 kDa and is encoded in humans by the IL10 gene, located on chromosome 1 and comprising 5 exon [8].”
BackgroundKotenko, S. V., Krause, C. D., Izotova, L. S., Pollack, B. P., Wu, W., & Pestka, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5894 · Cited by 381 · cited 2×
“[16] and later, it was observed in a model murine that a disruption of the IL-10Rβ chain led to IL-10 unresponsiveness [17].”
BackgroundThe Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor
Spencer, S. D., Di Marco, F., Hooley, J., Pitts-Meek, S., Bauer, M., Ryan, A. M., Sordat, B., Gibbs, V. C., & Aguet, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.571 · Cited by 368 · cited 1×
“[16] and later, it was observed in a model murine that a disruption of the IL-10Rβ chain led to IL-10 unresponsiveness [17].”
BackgroundIl10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology
Guillot-Sestier, M.-V., Doty, K. R., Gate, D., Rodriguez, J., Leung, B. P., Rezai-Zadeh, K., & Town, T. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.068 · Cited by 363 · cited 3×
“In addition, it was observed that the severity of cerebral amyloid angiopathy, characterized by the deposition of Aβ within the blood vessels walls, was also reduced in this animal model [71].”
BackgroundInfluentialChakrabarty, P., Li, A., Ceballos-Diaz, C., Eddy, J. A., Funk, C. C., Moore, B., DiNunno, N., Rosario, A. M., Cruz, P. E., Verbeeck, C., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.020 · Cited by 354
Saraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M., & O'Garra, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.012 · Cited by 315 · cited 1×
“IL-10 has been described to be produced by almost all leukocytes, including all T cell subsets, monocytes, macrophages, neutrophils, eosinophils, mast cells, dendritic cells (DCs), B and natural killer (NK) cells [9].”
BackgroundSerum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
Williams‐Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J. R., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., et al. (2016) · Movement Disorders · doi:10.1002/mds.26563 · Cited by 304 · cited 1×
“Similarly, in the analyses of newly diagnosed PD patients, IL-1β, TNFα, IL-2 and IL-10 resulted elevated [84].”
ResultBerlato, C., Cassatella, M. A., Kinjyo, I., Gatto, L., Yoshimura, A., & Bazzoni, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6404 · Cited by 267 · cited 7×
“Through SOCS-3 de novo synthesis, IL-10 has the capacity to inhibit the expression of a number of pro-inflammatory genes, including LPS-inducible cytokine genes, as TNF- α, IL-1, IL-6, IL-8, and IL-12; the IFN-γ inducible genes (MHC class II molecules, CD80/CD86, intercellular adhesion molecule-1 and inducible nitric…”
BackgroundInfluentialRole of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 262 · cited 1×
“, reported that IL-10 treatment could represent a potential therapy for AD, since this anti-inflammatory cytokine downregulating the pro-inflammatory cytokine expression could determine amyloid reduction [89].”
BackgroundRole of Interleukin-10 in Acute Brain Injuries
Garcia, J. M., Stillings, S. A., Leclerc, J. L., Phillips, H., Edwards, N. J., Robicsek, S. A., Hoh, B. L., Blackburn, S., & Doré, S. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00244 · Cited by 247
Schülke, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00455 · Cited by 238
A receptor for interleukin 10 is related to interferon receptors.
Ho, A. S., Liu, Y., Khan, T. A., Hsu, D. H., Bazan, J. F., & Moore, K. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11267 · Cited by 230 · cited 1×
“When IL-10 is produced and secreted, it acts specifically on the functional receptor complex of IL-10, which is composed of two subunits, IL-10R1 (IL-10Rα) and IL-10R2 (IL-10Rβ), both members of the interferon receptor (IFNR) family [15].”
BackgroundThe therapeutic potential of interleukin-10 in neuroimmune diseases
Kwilasz, A. J., Grace, P. M., Serbedzija, P., Maier, S. F., & Watkins, L. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.020 · Cited by 227 · cited 1×
“It was observed in the brains in the LPS-induced PD mouse model that IL-10 decreased the number of activated microglia with a protective effect regarding the loss of dopaminergic neuron [75].”
BackgroundDendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function
Melillo, J. A., Song, L., Bhagat, G., Blazquez, A. B., Plumlee, C. R., Lee, C., Berin, C., Reizis, B., & Schindler, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902960 · Cited by 225 · cited 2×
“cell activation other than resistance to IL-10-mediated suppression [26,27].”
BackgroundSu, F., Bai, F., & Zhang, Z. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0055-4 · Cited by 221 · cited 2×
“[63] showed that depending on the cytokines found in plasma of ALS patients, shorter (IL-1β and IL-12) or longer (IL-10) disease duration can be predicted, thus, suggesting that a lesser degree of inflammation might be associated with more favorable prognosis.”
BackgroundKiyota, T., Ingraham, K. L., Swan, R. J., Jacobsen, M. T., Andrews, S. J., & Ikezu, T. (2012) · Gene Therapy · doi:10.1038/gt.2011.126 · Cited by 217 · cited 1×
“In this regard, IL-10 overexpression in the hippocampus of AD transgenic mice has been reported to increase neurogenesis and enhance cognition, thus, evidencing the probable neuroprotective role played by IL-10 in this pathological condition [69].”
BackgroundInterleukin-10: A Pleiotropic Regulator in Pregnancy
Cheng, S.-B., & Sharma, S. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12329 · Cited by 184 · cited 6×
“Through SOCS-3 de novo synthesis, IL-10 has the capacity to inhibit the expression of a number of pro-inflammatory genes, including LPS-inducible cytokine genes, as TNF- α, IL-1, IL-6, IL-8, and IL-12; the IFN-γ inducible genes (MHC class II molecules, CD80/CD86, intercellular adhesion molecule-1 and inducible nitric…”
BackgroundInfluentialHenderson, V. W. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.010 · Cited by 181 · cited 1×
“These findings are supported by studies evidencing that post-menopausal administration of estrogens is responsible for the increase in IL-10 release by microglia, that, in turn, contributes to AD prevention [87,88].”
The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease
Menza, M., DeFronzo Dobkin, R., Marin, H., Mark, M. H., Gara, M., Bienfait, K., Dicke, A., & Kusnekov, A. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70739-8 · Cited by 180
Itakura, E., Huang, R.-R., Wen, D.-R., Paul, E., Wünsch, P. H., & Cochran, A. J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.5 · Cited by 174 · cited 1×
“In addition, keratinocytes and epithelial cells are reported to release IL-10 in response to infectious insult, tissue damage and the presence of tumor cells [10].”
BackgroundKarpenko, M. N., Vasilishina, A. A., Gromova, E. A., Muruzheva, Z. M., & Bernadotte, A. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.02.011 · Cited by 172 · cited 1×
“Moreover, PD patients with more severe clinical signs and a prognostically unfavorable non-tremor form show drastically reduced serum levels of IL-10 [76].”
BackgroundCalvello, R., Cianciulli, A., Nicolardi, G., De Nuccio, F., Giannotti, L., Salvatore, R., Porro, C., Trotta, T., Panaro, M. A., & Lofrumento, D. D. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9720-7 · Cited by 171 · cited 1×
“In this regard, the neuroprotective action done by vitamin D was attributed to upregulation of IL-10, in turn, shifting the microglial population from a pro-inflammatory phenotype to an anti-inflammatory one [95].”
BackgroundSelf-citationArimoto, T., Choi, D., Lü, X., Liu, M., Nguyen, X. V., Zheng, N., Stewart, C. A., Kim, H., & Bing, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.011 · Cited by 163 · cited 1×
“Confirming these observations, it was reported that loss of dopaminergic neurons, due to the intra-SN injection of LPS in mice, resulted selectively reduced after SN osmotic infusion of IL-10, containing microglial activation [92].”
BackgroundUnderstanding the neuroinflammatory response following concussion to develop treatment strategies
Patterson, Z. R., & Holahan, M. R. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00058 · Cited by 136 · cited 1×
“In this regard, neuroinflammation is characterized by the activation of resident glial cells, committed to central nervous system (CNS) immune surveillance, through the release of cytokines, chemokines, and other mediators, which, in turn, are able to recruit peripheral cells, including lymphocytes, monocytes and neut…”
BackgroundPeruzzaro, S., Andrews, M., Gharaibeh, A., Pupiec, O., Resk, M., Story, D. T., Maiti, P., Rossignol, J., & Dunbar, G. L. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1383-2 · Cited by 128 · cited 1×
“This result has been explained through the shifting of macrophages from pro-inflammatory to a pro-repair phenotype, thus, emphasizing the possible employment of IL-10 overexpression as a new therapeutic strategy for TBI treatment [57].”
BackgroundJin, M., Günther, R., Akgün, K., Hermann, A., & Ziemssen, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62756-8 · Cited by 124 · cited 1×
“Moreover, because the serum pro-inflammatory cytokines such as IL-1β, IL-6 and IFN-γ increased, whereas the anti-inflammatory IL-10 decreased, the authors correlated these events with disease severity and progression [65].”
BackgroundIL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells
Cianciulli, A., Dragone, T., Calvello, R., Porro, C., Trotta, T., Lofrumento, D. D., & Panaro, M. A. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.035 · Cited by 118 · cited 2×
“Moreover, treatment with resveratrol, a natural polyphenol with anti-inflammatory effects, is described to upregulate both IL-10 gene expression and IL-10 levels, with neuroprotective actions [35].”
BackgroundSelf-citationThe role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma
Berti, F. C. B., Pereira, A. P. L., Cebinelli, G. C. M., Trugilo, K. P., & de Oliveira, K. B. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.002 · Cited by 118
Gravel, M., Béland, L.-C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., & Kriz, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0854-15.2016 · Cited by 117 · cited 1×
“Recent studies conducted in an animal model of ALS evidenced a specific role for IL-10 in the early stage of disease, clearly demonstrating that this cytokine plays a crucial role in orchestrating the immune responses of microglial cells [59].”
ResultCognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide
Richwine, A. F., Sparkman, N. L., Dilger, R. N., Buchanan, J. B., & Johnson, R. W. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.02.020 · Cited by 111 · cited 1×
“, reported that in IL-10-deficient mice, LPS peripheral administration causes a noticeable cognitive deficit unlike what can be observed in wild-type mice [86].”
BackgroundHumoral factors in ALS patients during disease progression
Ehrhart, J. C., Smith, A. J., Kuzmin‐Nichols, N., Zesiewicz, T., Jahan, I., Shytle, R. D., Kim, S.-H., Sanberg, C. D., Vu, T., Gooch, C. L., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0350-4 · Cited by 109 · cited 1×
“In another study described by Ehrhart [64], no significant differences were observed in terms of anti-inflammatory IL-4 and IL-10 cytokine concentrations in ALS patients versus control subjects.”
BackgroundPeripheral blood inflammatory markers in early Parkinson’s disease
Kim, R., Kim, H.-J., Kim, A., Jang, M., Kim, A., Kim, Y., Yoo, D., Im, J. H., Choi, J.-H., & Jeon, B. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.079 · Cited by 103 · cited 1×
“Interestingly, a correlation between IL-10 levels and gastrointestinal symptoms in the early stage of PD was also recently reported, thus, reflecting a protective response against inflammatory processes associated with the disease [85].”
BackgroundMicroglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103 · cited 1×
“The neuroprotective M2 phenotype is characterized by the expression of IL-10, TGF-β and arginase and takes part in the resolution of inflammatory processes and tissue repair [32].”
BackgroundPérez-de Puig, I., Miró, F., Salas-Perdomo, A., Bonfill-Teixidor, E., Ferrer-Ferrer, M., Márquez-Kisinousky, L., & Planas, A. M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.155 · Cited by 101
Spinal Interleukin-10 Therapy to Treat Peripheral Neuropathic Pain
Milligan, E. D., Penzkover, K. R., Soderquist, R. G., & Mahoney, M. J. (2012) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2012.00462.x · Cited by 100 · cited 1×
“In addition, recent studies showed that IL-10Rα is expressed in retinal ganglion cells and in spinal cord neurons [39,40], suggesting that IL-10, probably, may modulate neuron functions independently from microglia and astrocytes.”
BackgroundCirculating interleukin-10 and interleukin-12 in Parkinson’s disease
Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., & Vassilopoulos, D. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01103.x · Cited by 99 · cited 1×
“Alternatively, high plasma IL-10 levels have been detected in PD patients with classical motor symptoms in comparison to healthy controls [77].”
BackgroundEssential role of IL-10/STAT3 in chronic stress-induced immune suppression
Hu, D., Wan, L., Chen, M., Caudle, Y., LeSage, G., Li, Q., & Yin, D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.10.016 · Cited by 97 · cited 1×
“Finally, displacement of Th1/Th2 cytokine balance determined by chronic stress was also recovered by blocking IL-10/STAT3 axis [29].”
BackgroundWilliams, L. M., Sarma, U., Willets, K., Smallie, T., Brennan, F., & Foxwell, B. M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609101200 · Cited by 94 · cited 4×
“cell activation other than resistance to IL-10-mediated suppression [26,27].”
BackgroundInfluentialPark, K. W., Lee, H. G., Jin, B. K., & Lee, Y. B. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.88 · Cited by 93 · cited 1×
“It follows that IL-10 production is submitted to a fine regulation by a number of signal molecules, including glutamate, prostaglandin E2, mycoepoxydiene; all these compounds are able to enhance IL-10 release by microglia cells via TLR-4 activation [33,34].”
BackgroundInterleukin-10 Is an Independent Biomarker of Severe Traumatic Brain Injury Prognosis
Soares, F. M. S., de Souza, N. M., Schwarzbold, M. L., Díaz, A. P., Nunes, J. C., Hohl, A., da Silva, P. N. A., Vieira, J., de Souza, R. L., Bertotti, M. M., et al. (2012) · NeuroImmunoModulation · doi:10.1159/000342141 · Cited by 90 · cited 5×
“Traumatic brain injury (TBI) is characterized by a complex devastating injury with a broad spectrum of symptoms and disabilities, in which neuroinflammation plays a crucial role, being both protective and detrimental for brain compartments.”
ResultInfluentialBoyd, Z. S., Kriatchko, A., Yang, J., Agarwal, N., Wax, M. B., & Patil, R. V. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0534 · Cited by 85 · cited 1×
“In addition, recent studies showed that IL-10Rα is expressed in retinal ganglion cells and in spinal cord neurons [39,40], suggesting that IL-10, probably, may modulate neuron functions independently from microglia and astrocytes.”
BackgroundIL-10–treated dendritic cells decrease airway hyperresponsiveness and airway inflammation in mice
Koya, T., Matsuda, H., Takeda, K., Matsubara, S., Miyahara, N., Balhorn, A., Dakhama, A., & Gelfand, E. W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.039 · Cited by 85 · cited 1×
“IL-10 is generally reported as an anti-inflammatory cytokine with multiple immunoregulatory effects particularly important during the resolution phase [11].”
BackgroundIL-10 promotes survival of microglia without activating Akt
Strle, K., Zhou, J.-H., Broussard, S. R., Venters, H., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00444-1 · Cited by 84 · cited 1×
“In the course of CNS pathology, the levels of IL-10 significantly increase in the brain in order to ensure nervous tissue survival and mitigate inflammatory responses triggering several signaling pleiotropic pathways [7].”
BackgroundO’Neill, E. J., Day, M. J., & Wraith, D. C. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.030 · Cited by 79 · cited 1×
“These observations were confirmed by what was found in mouse models of experimental autoimmune encephalomyelitis (EAE), in which the increase in IL-10 levels leads to symptoms reduction [43].”
ResultCognition and the menopause transition
Maki, P. M., & Henderson, V. W. (2016) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000681 · Cited by 73
Rasley, A., Tranguch, S. L., Rati, D. M., & Marriott, I. (2006) · Glia · doi:10.1002/glia.20314 · Cited by 72
Anti-inflammatory Signaling in Microglia Exacerbates Alzheimer’s Disease-Related Pathology
Michaud, J.-P., & Rivest, S. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.021 · Cited by 71 · cited 1×
“Conversely, other studies seem to support a detrimental effect by IL-10 causing Aβ clearance, inhibition in microglia, and worsening cognitive decline in AD mouse models [70].”
ResultWiciński, M., Wódkiewicz, E., Słupski, M., Walczak, M., Socha, M. W., Malinowski, B., & Pawlak-Osińska, K. (2018) · BioMed Research International · doi:10.1155/2018/6091014 · Cited by 69 · cited 1×
“Interestingly, a recent work reported as possible drug candidate sitagliptin, producing, among its biological effects, an IL-10 increase in the treatment of certain neurodegenerative disorders linked with neuroinflammation, with special emphasis on AD [90].”
BackgroundCSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy
Furukawa, T., Matsui, N., Fujita, K., Nodera, H., Shimizu, F., Miyamoto, K., Takahashi, Y., Kanda, T., Kusunoki, S., Izumi, Y., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000138 · Cited by 66 · cited 1×
“Moreover, it was reported that IL-10 levels resulted high in ALS patients exhibiting a slowly progressive course or mild symptoms, thus, suggesting a possible neuroprotective action by this cytokine [62].”
BackgroundAnti-inflammatory effect of physical training in heart failure: role of TNF-alpha and IL-10.
Júnior, M. L. B., Júnior, M. L. B., Lópes, R. D., Seelaender, M. C. L., & Lopes, A. C. (2009) · PubMed · Cited by 65
Kirchhoff, C., Buhmann, S., Bogner, V., Stegmaier, J., Leidel, B. A., Braunstein, V., Mutschler, W., & Biberthaler, P. (2008) · PubMed · Cited by 62
Panaro, M. A., & Cianciulli, A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799040574 · Cited by 62 · cited 1×
“Neuroinflammation is an important risk factor that may contribute to PD pathogenesis, since PD patients suffer from chronic inflammation that probably precedes neurodegeneration and cytokines produced by activated microglia in the substantia nigra (SN) and putamen in the course of PD [74].”
BackgroundSelf-citationZhu, Y., Liu, Z., Peng, Y.-P., & Qiu, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.017 · Cited by 61 · cited 1×
“At the same time, IL-10 suppressed the upregulation of active forms of caspase-3 and caspase-9 induced by LPS reducing neuronal apoptosis, thus, suggesting that IL-10 has neuroprotective effects against LPS by downregulating pro-inflammatory cytokines mediated neuronal apoptosis [91].”
BackgroundOkada, Y., Ochi, H., Fujii, C., Hashi, Y., Hamatani, M., Ashida, S., Kawamura, K., Kusaka, H., Matsumoto, S., Nakagawa, M., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.10.011 · Cited by 61 · cited 1×
“B cells from MS patients are deficient in their capacity to produce IL-10 after either TLR9 or CD40 stimulation, whereas TLR4-mediated IL-10 production was restored to normal levels in MS and further increased at relapse in the presence of CD40 signaling, thus, demonstrating that regulation of TLR4 and CD40 signaling…”
BackgroundAssociation Between Cytokines and Cerebral MRI Changes in the Aging Brain
Baune, B. T., Ponath, G., Rothermundt, M., Roesler, A., & Berger, K. (2009) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708328216 · Cited by 58 · cited 1×
“Analyzing the association between candidate peripheral biomarkers (including amyloid beta, cytokines and serum total fatty acids) with brain TSPO levels, they found that serum IL-6 and IL-10 are higher in AD compared to the aMCI and healthy volunteers, whereas serum amyloid beta, cytokines and fatty acids were general…”
BackgroundLagerstedt, L., Egea-Guerrero, J. J., Rodríguez-Rodríguez, A., Bustamante, A., Montaner, J., Rahal, A. E., Andereggen, É., Rinaldi, L., Sarrafzadeh, A. S., Schaller, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193278 · Cited by 58
Li, Z., Zeng, G., Zheng, X., Wang, W., Ling, Y., Tang, H., & Zhang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.041 · Cited by 57
Mun, M.-J., Kim, J.-H., Choi, J.-Y., & Jang, W.-C. (2016) · Meta Gene · doi:10.1016/j.mgene.2016.01.001 · Cited by 53
Dallé, E., Daniels, W. M. U., & Mabandla, M. V. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.005 · Cited by 52 · cited 1×
“In this regard, in another PD animal model represented by a 6-OHDA rat model, it was reported that Fluvoxamine treatment attenuated neuronal inflammation, reducing lipid peroxidation, as well as IL-1β, IL-6 and TNFα mRNA levels, while IL-10 and TGF-β levels resulted upregulated in the striatum of treated animals [96].”
BackgroundEffect of age on surface molecules and cytokine expression in human dendritic cells
Ciaramella, A., Spalletta, G., Bizzoni, F., Salani, F., Caltagirone, C., & Bossù, P. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.04.010 · Cited by 46 · cited 1×
“As confirmation of this last observation, it is noteworthy that IL-10 production becomes deregulated with aging, resulting in reactive microgliosis and neuronal stress [60].”
BackgroundKorniotis, S., Gras, C., Letscher, H., Montandon, R., Megret, J., Siegert, S., Ezine, S., Fallon, P. G., Luther, S. A., Fillatreau, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12134 · Cited by 45 · cited 1×
“Consistent to this finding, previous studies reported that CD40 stimulation triggered continuous IL-10 production by human B cells in response to TLR stimulation correlating with B cell-mediated recovery from EAE by IL-10 production [48,49], promising a novel therapeutic approach for MS.”
ResultKim, R. B., Irvin, C. W., Tilva, K. R., & Mitchell, C. S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1047455 · Cited by 42
Cytokine Gene Polymorphisms and Parkinson's Disease: A Meta-Analysis
Chu, K.-T., Zhou, X., & Benyan, L. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012695 · Cited by 41 · cited 1×
“In this regard, some observations evidenced no association [80,81], although other studies showed that IL-10 promoter polymorphisms−819 and −1082 seem to be associated with PD risk and early PD occurrence [82].”
ResultJoniec-Maciejak, I., Ciesielska, A., Wawer, A., Sznejder-Pachołek, A., Schwenkgrub, J., Cudna, A., Hadaczek, P., Bankiewicz, K., Członkowska, A., & Członkowski, A. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.008 · Cited by 40
Vinpocetine regulates levels of circulating TLRs in Parkinson’s disease patients
Ping, Z., Wu, X., Xufang, X., & Shao, L. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3592-y · Cited by 38 · cited 1×
“In fact, in vivo administration of vinpocetine reduced serum levels of inflammatory cytokines, TNFα and MCP-1, increasing significantly IL-10 [97].”
BackgroundLi, D., Song, X., Huang, H., Huang, H., & Ye, Z. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.027 · Cited by 38
Cisbani, G., Koppel, A., Knezevic, D., Suridjan, I., Mizrahi, R., & Bazinet, R. P. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.02.014 · Cited by 37 · cited 1×
“In the aging brain, a combination of cytokines, such as IL-1β, IL-6, IL-8, IL-10, IL-12 and TNFα, is reported to trigger inflammatory processes associated with cortical atrophy [67].”
BackgroundGutierrez-Murgas, Y. M., Skar, G. L., Ramirez, D., Beaver, M., & Snowden, J. N. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0741-1 · Cited by 37
Schwenkgrub, J., Joniec‐Maciejak, I., Sznejder-Pachołek, A., Wawer, A., Ciesielska, A., Bankiewicz, K. S., Członkowska, A., & Członkowski, A. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)70962-9 · Cited by 35 · cited 1×
“Moreover, in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD, which causes striatal tyrosine hydroxylase depletion and subsequent dopaminergic cell death, the adeno-associated viral type-2 vector containing the complementary DNA for human IL-10, injected intracerebroventricularly before MPTP injectio…”
BackgroundYen, J.-H. J., Xu, S., Park, Y. S., Ganea, D., & Kim, K. C. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.004 · Cited by 33 · cited 6×
“A genetic vaccine containing the hsp65 mycobacterial gene resulted able to reduce EAE clinical signs and trigger higher IL-10 production in the CNS, thus, evidencing how IL-10 may represent one of the most effective anti-inflammatory cytokines for MS control [99].”
BackgroundInfluentialPascale, E., Passarelli, E., Purcaro, C., Vestri, A. R., Fakeri, A., Guglielmi, R., Passarelli, F., & Meco, G. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01441.x · Cited by 32 · cited 1×
“In this regard, some observations evidenced no association [80,81], although other studies showed that IL-10 promoter polymorphisms−819 and −1082 seem to be associated with PD risk and early PD occurrence [82].”
ResultInterleukin-10 polymorphisms in Spanish Multiple Sclerosis patients
Doncel, A. M., Rubio, A., Arroyo, R., Heras, V. D. L., Martín, C. E. S., Fernández‐Arquero, M., & de la Concha, E. G. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00248-5 · Cited by 32 · cited 1×
“Apart from the aforementioned cytokines involved in pro-inflammatory effects observed in the CNS of both MS patients and in animal models, there is evidence for the presence of several other cytokines, including IL-10, actively implicated in anti-inflammatory events in an attempt to assure the axonal and myelin integr…”
BackgroundBai, X., Wang, X.-F., Zhang, L., Du, P., Cao, Z., & Hou, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.143 · Cited by 32
Klose, J., Schmidt, N. O., Melms, A., Dohi, M., Miyazaki, J., Bischof, F., & Greve, B. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-117 · Cited by 29 · cited 6×
“A genetic vaccine containing the hsp65 mycobacterial gene resulted able to reduce EAE clinical signs and trigger higher IL-10 production in the CNS, thus, evidencing how IL-10 may represent one of the most effective anti-inflammatory cytokines for MS control [99].”
BackgroundInfluentialInterleukin-10 Modulation of Virus Clearance and Disease in Mice with Alphaviral Encephalomyelitis
Martin, N., & Griffin, D. E. (2017) · Journal of Virology · doi:10.1128/jvi.01517-17 · Cited by 26 · cited 10×
“Interestingly, IL-10 deficient mice show uncontrolled inflammation and increased susceptibility to bacterial, parasitic and viral infections in the CNS [36,37].”
BackgroundInfluentialInterleukin-10 promoter polymorphisms in Chinese patients with Parkinson's disease
Li, D., He, Q., Li, R., Xu, X., Chen, B., & Xie, A. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.033 · Cited by 26 · cited 1×
“In this regard, some observations evidenced no association [80,81], although other studies showed that IL-10 promoter polymorphisms−819 and −1082 seem to be associated with PD risk and early PD occurrence [82].”
ResultHosseini, A., Estiri, H., Akhavan‐Niaki, H., Alizadeh, A., zadeh, B. A., Ghaderian, S. M. H., Farjadfar, A., & Fallah, A. (2017) · PubMed Central · doi:10.22074/cellj.2017.4497 · Cited by 20
Chen, H., Lin, W. J., Lin, P., Zheng, M., Lai, Y., Chen, M., Zhang, Y., Chen, J., Lin, X., Lin, L., et al. (2019) · Aging · doi:10.18632/aging.102411 · Cited by 16 · cited 1×
“These findings demonstrated the potential therapeutic value of IL-10 in cerebral ischemia [93].”
BackgroundObál, I., Klausz, G., Mándi, Y., Deli, M. A., Siklós, L., & Engelhardt, J. I. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0586-7 · Cited by 13 · cited 9×
“and in the serum of mice injected intraperitoneally with the IgG from the ALS patients accompanied with subclinical signs of motoneuron diseases, thus, evidencing the importance of the delicate balance between the pro- and anti-inflammatory mechanisms in neurodegeneration such as ALS [61].”
BackgroundInfluentialZorzella-Pezavento, S. F. G., Chiuso‐Minicucci, F., França, T. G. D., Ishikawa, L. L. W., da Rosa, L. C., Colavite, P. M., Balbino, B., Marques, C., Ikoma, M. R. V., Masson, A. P., et al. (2017) · Journal of Immunology Research · doi:10.1155/2017/6257958 · Cited by 9
Bai, F., Xie, C., Yuan, Y., Shi, Y., & Zhang, Z. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.11.019 · Cited by 8 · cited 1×
“On the other hand, a recent study [72] reported that promoter haplotypes of IL-10 may be important modulators of the development of amnestic mild cognitive impairment, thus, confirming previous observations regarding the linkage of polymorphisms in the promoter region of IL-10 and risk factors of AD [73].”
Result
Cited by
Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Thakur, S., Dhapola, R., Sarma, P., Medhi, B., & Reddy, D. H. (2023) · Inflammation · doi:10.1007/s10753-022-01721-1 · Cited by 557
“Further exploration withstand these findings, as adeno-associated virus–mediated IL-10 expression accelerates the burden of amyloid beta, and cognitive dysfunctioning was observed to worsen in AD animal models [41].”
BackgroundCarlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Al-Qahtani, A. A., Alhamlan, F. S., & Al-Qahtani, A. A. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9010013 · Cited by 291
Rani, V., Verma, R., Kumar, K., & Chawla, R. (2023) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100149 · Cited by 93
Nkadimeng, S. M., Steinmann, C. M., & Eloff, J. N. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s317182 · Cited by 83
Metadata
- Authors
- Porro, C., Cianciulli, A., & Panaro, M. A.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-07-09
- Volume
- 10
- Issue
- 7
- Pages
- 1017
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W3041707034
- Cited by
- 249
- References
- 102
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.